Ubs Ag Etracs Gold Shares Covered Call Etn logo

Ubs Ag Etracs Gold Shares Covered Call Etn(GLDI)

$157.49-0.52%

Market is closed - opens 8 PM, 11 Nov 2024

Insights

  • Ubs Ag Etracs Gold Shares Covered Call Etn is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
  • Based on analysis of the Oscillators technical indicator, the current market trend for Ubs Ag Etracs Gold Shares Covered Call Etn stock suggests that it is range bound and no decision can be made based on this information
  • Based on analysis of the Moving Averages technical indicator, Ubs Ag Etracs Gold Shares Covered Call Etn stock is Range bound.
  • Based on analysis of the Pivot Points, the current market trend for Ubs Ag Etracs Gold Shares Covered Call Etn stock suggests that it is a good time to buy

Analysis Summary

Oscillators

Sell

Neutral

Buy

Moving Averages

Sell

Neutral

Buy

Pivots

Sell

Neutral

Buy

Oscillators

Name

Value

Action

Relative Strength Index
54.18
Neutral
Stochastic
57.74, 41.68
Neutral
Ultimate Oscillator
57.29
Neutral
Stochastic Relative Strength Index
16.87, 19.67
Neutral
Moving Average Convergence Divergence
0.51, 0.73
Sell

Moving Averages

Simple Moving Average

Period (Days)

Value

Action

10
158.29
Buy
20
158.17
Buy
50
156.29
Buy

Exponential Moving Average

Period (Days)

Value

Action

10
158.07
Buy
20
157.82
Buy
50
156.31
Buy

Volume Weighted Moving Average

Period (Days)

Value

Action

10
157.82
Neutral
20
158.18
Neutral
50
156.48
Neutral

Double Exponential Moving Average

Period (Days)

Value

Action

10
158.08
Sell
20
158.6
Sell
50
158.8
Buy

Triple Exponential Moving Average

Period (Days)

Value

Action

10
157.76
Sell
20
158.28
Sell
50
159.08
Buy

Pivot

Pivot

Value

Resistance L3
158.33
Resistance L2
157.4
Resistance L1
156.85
Pivot Point
155.92
Support L1
155.37
Support L2
154.44
Support L3
153.89

*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.